Pet Cancer Therapeutics Market
Market Survey on Pet Cancer Therapeutics Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Pet Cancer Therapeutics Market including Chemotherapy, Immunotherapy, Targeted Therapy, and Combination Therapy Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Pet Cancer Therapeutics Market Outlook
The global pet cancer therapeutics market size is set to reach US$ 405.90 billion in 2023. Overall sales of pet cancer therapeutics are likely to surge at 10% CAGR, taking the forecasted market valuation to US$ 1052.80 billion by the end of 2033.
Alternative therapies, such as acupuncture, herbal remedies, and dietary supplements, are becoming increasingly accepted as a means of alleviating some of the discomfort associated with conventional cancer treatments and enhancing the health of pets as a whole. These treatments are not meant to be used in place of standard care, but they can provide comfort and assistance during chemotherapy for pets.
Precision medicine, or personalised medicine, is the practise of customising medical care to each patient by taking into account their unique genetic makeup and molecular profile. As scientists learn more about the genetic mutations that cause various canine and feline cancers, this method is gaining prominence in the field. If veterinarians can pinpoint these mutations, they can create targeted therapies that outperform standard chemotherapy.
Developed nations like the United States and Europe have seen the greatest increases in the number of people keeping pets as companions. More pet owners are willing to spend money on treatments to ensure their pets' health and happiness, increasing demand for pet cancer therapeutics.
Technology advancements have facilitated the detection and treatment of cancer in pets. PET/CT scans, for example, are helping veterinarians diagnose cancer more precisely, and developments in surgery and anaesthesia have made it easier and safer to operate on pets with the disease. This is improving pet survival rates and making it easier for pet owners to afford cancer treatment.
New drugs and treatment methods are being developed thanks to the increased focus on pet cancer research. The rising incidence of cancer in pets is one factor, but technological advancements are also facilitating research into the disease. Gene sequencing has been instrumental in the discovery of the genetic mutations that underlie various forms of cancer, thereby paving the way for the development of targeted therapies.
Attributes |
Details |
Pet Cancer Therapeutics Market CAGR (2023 to 2033) |
10% |
Pet Cancer Therapeutics Market Size (2023) |
US$ 405.90 billion |
Pet Cancer Therapeutics Market Size (2033) |
US$ 1052.80 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Pet Cancer Therapeutics Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)
According to recent research by Future Market Insights, the pet cancer therapeutics market is projected to expand at a rate of 10% during the forecast period from 2023 to 2033. The market outlook could be divided into short term, medium term and long term.
Short term (2023 to 2025): Many pet owners are prepared to pay more than ever before for their pets' medical care. More and more people are spending money on cancer treatments for their pets, and this is a major factor in the expansion of the pet cancer therapeutics market. Since pets are increasingly considered members of the family, their owners are willing to invest large sums of money into their care.
Medium term (2025 to 2028): Cancer in pets is a growing concern for pet owners as they learn more about preventative care. This realisation has increased the demand for cancer screenings and treatments that aim to identify the disease at an early stage. Many pet owners now include annual checkups, diagnostic testing, and cancer screening as part of their routine care because early detection is key to successful treatment.
Long term (2028 to 2033): Improvements in veterinary medicine and the prevalence of preventative care have led to the increased longevity of domesticated animals. However, the likelihood of contracting cancer rises with chronological age. Demand for cancer treatments that can extend the lives of pets while keeping their quality of life intact is rising as a result of this trend. The need for efficient cancer treatments is growing as pet lifespans rise along with the prevalence of cancer.
Comparative Adjacent Table
Pet Cancer Therapeutics Market:
Attributes |
Pet Cancer Therapeutics Market |
CAGR (2023 to 2033) |
10% |
Market Value (2026) |
US$ 1052.80 billion |
Growth Factor |
Rise in the prevalence of pet cancer |
Opportunity |
Rapid increase in funding for cancer therapy research activities |
Restraints |
Lack of veterinary oncologists |
Cancer Supportive Care Drugs Market:
Attributes |
Cancer Supportive Care Drugs Market |
CAGR (2023 to 2033) |
2.2% |
Market Value (2026) |
US$ 26053.36 million |
Growth Factor |
Rising geriatric population, which is more susceptible to cancer |
Opportunity |
Growing focus on personalized medicine and targeted therapies |
Restraints |
Side effects associated with these drugs, which may lead to reduced patient compliance |
Veterinary Oncology Market:
Attributes |
Veterinary Oncology Market |
CAGR (2023 to 2033) |
12.1% |
Market Value (2026) |
US$ 812.88 million |
Growth Factor |
Growing demand for pet insurance and healthcare services |
Opportunity |
Development of novel and targeted therapies for animal cancer treatment |
Restraints |
Limited availability of specialized veterinary oncologists |
What are the drivers in the market?
The rapid uptake of cutting-edge, novel medicines for pet care is driving growth in the pet cancer therapeutics market. The global market is being propelled by the fact that more and more people are able to afford to get pets, particularly dogs and cats. The rising incidence of cancer in pets is driving up the demand for therapeutics to treat the disease, and pet owners are responding by spending more money on their animals' health. There will be new products on the market in the coming years as a result of manufacturers' heavy investment in R&D to develop new treatments for pet cancer. Market dominators with a wide selection of products will increase their share of the industry by producing ground-breaking medicines. The market could expand more quickly if more people knew about the dangers of pet cancer drugs and other illnesses. The high price of cancer therapeutics for pets is also likely to be a problem, especially in less developed regions of the world.
What is restraining the market growth?
The potential severity of adverse effects from some cancer therapeutics for pets is a major deterrent to owners seeking care for their animals. Animals undergoing chemotherapy, for instance, often experience gastrointestinal distress and hair loss. Radiation therapy has similar side effects, including skin irritation and tiredness. These negative effects can discourage pet owners from pursuing treatment and lower the quality of life for their pets.
The importance of early detection and treatment for canine and feline cancers is not widely known among pet owners. As a result, pets with cancer may not receive timely treatment, which can lessen the effectiveness of that treatment and worsen their prognoses.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
What are the challenges that the market is facing?
The high cost of cancer therapeutics for pets is a major deterrent for some owners. This is especially true in less developed regions, where pet owners may not have ready access to veterinary care of the highest standard.
Although there have been great strides in the treatment of cancer in pets in recent years, there are still some types of cancer for which there are few options. This can make effective treatment for some pets with cancer more challenging to provide.
Some pet owners may opt for less conventional cancer therapies, such as acupuncture or herbal medicine, for their pets. These treatments may be more affordable, but they aren't always supported by science and may not be effective against pet cancer.
Regional Analysis
What is driving the United States Pet Cancer Therapeutics Market?
More people than ever before are keeping pets as companions, and this trend can be seen all over the world. Over 67% of American households currently have a pet, according to the American Pet Products Association, continuing a trend of rising pet ownership over the past three decades. The need for veterinary services, such as cancer treatment, is rising in tandem with the pet population. As a result, the market for pet cancer therapeutics is expanding as more and more people look for novel and effective therapies for their pets.
How is the Indian Pet Cancer Therapeutics Market expected to grow during the forecast period?
During the predicted time period, the market for cancer therapeutics for pets in India is projected to expand at a healthy rate. The growth of the market in India is anticipated to be driven by factors such as the increasing adoption rate of pets, increased awareness of pet healthcare, and rising expenditure on pet healthcare. The availability of cutting-edge cancer treatments for pets and the proliferation of veterinary hospitals and clinics across the country are also factors that will drive demand.
Reports estimate that between 2021 and 2026, the Indian market for pet cancer therapeutics will increase from its 2020 valuation of about USD 17.8 million by a compound annual growth rate (CAGR) of about 9.5%. The rising incidence of pet cancer and the subsequent demand for efficient cancer treatments are major factors driving the market.
Furthermore, the Indian government has launched various pet health insurance schemes and increased public awareness campaigns to promote pet healthcare and welfare. As a result of these actions, the pet cancer therapeutics market in India is expected to expand.
What is the Japanese Pet Cancer Therapeutics Market Outlook?
According to market research, the value of the Japanese pet cancer therapeutics market was around USD 25 million in 2020, and it is expected to grow at a CAGR of around 8% between 2021 and 2026. The availability of novel therapeutics and the rising demand for cutting-edge cancer treatments for pets are driving the market forward.
However, the market expansion may be stymied by the high price of pet cancer treatments and the scarcity of effective treatments for some types of pet cancer. It will be crucial for the future development of the Japanese pet cancer therapeutics market to address these issues and increase access to effective pet cancer therapeutics.
Category Wise Insights
The market for oral pet cancer therapeutics is expected to be worth more than US$ 359 million by 2032. Growth in this market segment is being bolstered by the significant advances in oral medicines because of the clinical benefits they offer, such as the convenience and comfort of home therapy and fewer clinic visits. The first oral chemotherapy pill for dogs with lymphoma, Laverdia-CA1 (also known as Verdinexor), was conditionally approved by the FDA in May 2022. These capsules can enhance chemotherapeutic agents' ability to inhibit cancer cell proliferation by inducing apoptosis.
The dog species segment of the pet cancer therapeutics market is expected to be worth over US$ 352 million by 2022 as a result of increasing penetration and a rise in the occurrences of feline cancer. Additionally, risk factors associated with in-breeding and mixed-breed dogs have increased the likelihood of tumours and lymph. In a recent study from 2022, the researchers found that the increased longevity of dogs was a major factor in the detection of cancer at an early stage. This increase was attributed to natural selection favouring the survival of pets that were kept in sterile environments and given access to better medical care. According to the study's findings, the global cancer rate has risen in tandem with the ageing dog population.
Competitive Landscape
Zoetis Inc., Merial Inc., Elanco Animal Health, Anivive Lifesciences, Qbiotics, AB Science, NovaVive, and ELIAS Animal Health are just some of the major players in the market for cancer therapeutics for pets. To stay ahead of the competition, these companies are investing in research and development programmes for brand new products. For instance, in June of 2022, Boehringer Ingelheim, a biopharmaceutical company, and CarthroniX, a developer of small molecule-based therapies for ageing-related and degenerative diseases, announced a collaboration to advance the field of canine oncology through the discovery and development of novel small molecule therapeutics. This new approach to canine cancer treatment is likely to aid Boehringer Ingelheim in expanding its Animal Health division.
Key Segments
Pet Cancer Therapeutics Industry by Therapy:
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
Pet Cancer Therapeutics Industry by Route of Administration:
- Oral
- Injection
Pet Cancer Therapeutics Industry by Species:
- Dogs
- Cats
Pet Cancer Therapeutics Industry by Application:
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Others
Pet Cancer Therapeutics Industry by Geography:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
Frequently Asked Questions
Why is the United States Market Witnessing Higher Growth?
The rising generic populations are fueling the demand in the United States.
Why is Sales of Pet Cancer Therapeutics Surging in Europe?
The growing focus on medicine and targeted therapies in Europe has increased the demand.
What is Driving the Adoption of Pet Cancer Therapeutics Globally?
Healthcare experts have necessitated pet cancer therapeutics adoption.
What is the Contribution of the United States in the Market?
The United States hold a share of 67% of the global market in 2023.
Which Region Presents Lucrative Growth Opportunities?
North America to witness lucrative growth opportunities through 2033.
Table of Content
1. Executive Summary | Pet Cancer Therapeutics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2022 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Therapy 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Therapy, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy, 2022 to 2033 5.3.1. Chemotherapy 5.3.2. Immunotherapy 5.3.3. Targeted Therapy 5.3.4. Combination Therapy 5.4. Y-o-Y Growth Trend Analysis By Therapy, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Therapy, 2022 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Route of Administration 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2022 to 2033 6.3.1. Oral 6.3.2. Injection 6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Pet 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Pet , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Pet , 2022 to 2033 7.3.1. Dogs 7.3.2. Cats 7.4. Y-o-Y Growth Trend Analysis By Pet , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Pet , 2022 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2033 8.3.1. Lymphoma Cancer 8.3.2. Mast Cell Cancer 8.3.3. Melanoma Cancer 8.3.4. Mammary Cancer 8.3.5. Squamous Cell Cancer 8.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Application, 2022 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Therapy 10.2.3. By Route of Administration 10.2.4. By Pet 10.2.5. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Therapy 10.3.3. By Route of Administration 10.3.4. By Pet 10.3.5. By Application 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Therapy 11.2.3. By Route of Administration 11.2.4. By Pet 11.2.5. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Therapy 11.3.3. By Route of Administration 11.3.4. By Pet 11.3.5. By Application 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Therapy 12.2.3. By Route of Administration 12.2.4. By Pet 12.2.5. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Therapy 12.3.3. By Route of Administration 12.3.4. By Pet 12.3.5. By Application 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Therapy 13.2.3. By Route of Administration 13.2.4. By Pet 13.2.5. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Therapy 13.3.3. By Route of Administration 13.3.4. By Pet 13.3.5. By Application 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Therapy 14.2.3. By Route of Administration 14.2.4. By Pet 14.2.5. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Therapy 14.3.3. By Route of Administration 14.3.4. By Pet 14.3.5. By Application 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Therapy 15.2.3. By Route of Administration 15.2.4. By Pet 15.2.5. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Therapy 15.3.3. By Route of Administration 15.3.4. By Pet 15.3.5. By Application 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2022 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Therapy 16.2.3. By Route of Administration 16.2.4. By Pet 16.2.5. By Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Therapy 16.3.3. By Route of Administration 16.3.4. By Pet 16.3.5. By Application 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Therapy 17.1.2.2. By Route of Administration 17.1.2.3. By Pet 17.1.2.4. By Application 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Therapy 17.2.2.2. By Route of Administration 17.2.2.3. By Pet 17.2.2.4. By Application 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Therapy 17.3.2.2. By Route of Administration 17.3.2.3. By Pet 17.3.2.4. By Application 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Therapy 17.4.2.2. By Route of Administration 17.4.2.3. By Pet 17.4.2.4. By Application 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Therapy 17.5.2.2. By Route of Administration 17.5.2.3. By Pet 17.5.2.4. By Application 17.6. United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Therapy 17.6.2.2. By Route of Administration 17.6.2.3. By Pet 17.6.2.4. By Application 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Therapy 17.7.2.2. By Route of Administration 17.7.2.3. By Pet 17.7.2.4. By Application 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Therapy 17.8.2.2. By Route of Administration 17.8.2.3. By Pet 17.8.2.4. By Application 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Therapy 17.9.2.2. By Route of Administration 17.9.2.3. By Pet 17.9.2.4. By Application 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Therapy 17.10.2.2. By Route of Administration 17.10.2.3. By Pet 17.10.2.4. By Application 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Therapy 17.11.2.2. By Route of Administration 17.11.2.3. By Pet 17.11.2.4. By Application 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Therapy 17.12.2.2. By Route of Administration 17.12.2.3. By Pet 17.12.2.4. By Application 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Therapy 17.13.2.2. By Route of Administration 17.13.2.3. By Pet 17.13.2.4. By Application 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Therapy 17.14.2.2. By Route of Administration 17.14.2.3. By Pet 17.14.2.4. By Application 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Therapy 17.15.2.2. By Route of Administration 17.15.2.3. By Pet 17.15.2.4. By Application 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Therapy 17.16.2.2. By Route of Administration 17.16.2.3. By Pet 17.16.2.4. By Application 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Therapy 17.17.2.2. By Route of Administration 17.17.2.3. By Pet 17.17.2.4. By Application 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Therapy 17.18.2.2. By Route of Administration 17.18.2.3. By Pet 17.18.2.4. By Application 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Therapy 17.19.2.2. By Route of Administration 17.19.2.3. By Pet 17.19.2.4. By Application 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Therapy 17.20.2.2. By Route of Administration 17.20.2.3. By Pet 17.20.2.4. By Application 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Therapy 17.21.2.2. By Route of Administration 17.21.2.3. By Pet 17.21.2.4. By Application 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Therapy 18.3.3. By Route of Administration 18.3.4. By Pet 18.3.5. By Application 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Zoetis, Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Elanco Animal Health 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Boehringer Ingelheim International GmbH 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Dechra Pharmaceuticals 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. AB Science 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Qbiotics 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. NovaVive, Inc. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. ELIAS Animal Health 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Karyopharm Therapeutics, Inc. 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Torigen Pharmaceuticals Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Europe Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 18: Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 19: Europe Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 20: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 23: South Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 24: South Asia Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 25: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 29: East Asia Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 30: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: Oceania Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 33: Oceania Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 34: Oceania Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 35: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033 Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: MEA Market Value (US$ Million) Forecast by Therapy, 2018 to 2033 Table 38: MEA Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 39: MEA Market Value (US$ Million) Forecast by Pet , 2018 to 2033 Table 40: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
List of Charts
Figure 1: Global Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 2: Global Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 3: Global Market Value (US$ Million) by Pet , 2022 to 2033 Figure 4: Global Market Value (US$ Million) by Application, 2022 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2022 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 21: Global Market Attractiveness by Therapy, 2022 to 2033 Figure 22: Global Market Attractiveness by Route of Administration, 2022 to 2033 Figure 23: Global Market Attractiveness by Pet , 2022 to 2033 Figure 24: Global Market Attractiveness by Application, 2022 to 2033 Figure 25: Global Market Attractiveness by Region, 2022 to 2033 Figure 26: North America Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 27: North America Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 28: North America Market Value (US$ Million) by Pet , 2022 to 2033 Figure 29: North America Market Value (US$ Million) by Application, 2022 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 46: North America Market Attractiveness by Therapy, 2022 to 2033 Figure 47: North America Market Attractiveness by Route of Administration, 2022 to 2033 Figure 48: North America Market Attractiveness by Pet , 2022 to 2033 Figure 49: North America Market Attractiveness by Application, 2022 to 2033 Figure 50: North America Market Attractiveness by Country, 2022 to 2033 Figure 51: Latin America Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 52: Latin America Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 53: Latin America Market Value (US$ Million) by Pet , 2022 to 2033 Figure 54: Latin America Market Value (US$ Million) by Application, 2022 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 71: Latin America Market Attractiveness by Therapy, 2022 to 2033 Figure 72: Latin America Market Attractiveness by Route of Administration, 2022 to 2033 Figure 73: Latin America Market Attractiveness by Pet , 2022 to 2033 Figure 74: Latin America Market Attractiveness by Application, 2022 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2022 to 2033 Figure 76: Europe Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 77: Europe Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 78: Europe Market Value (US$ Million) by Pet , 2022 to 2033 Figure 79: Europe Market Value (US$ Million) by Application, 2022 to 2033 Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2033 Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 84: Europe Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 85: Europe Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 87: Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 88: Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 90: Europe Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 91: Europe Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 93: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 94: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 95: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 96: Europe Market Attractiveness by Therapy, 2022 to 2033 Figure 97: Europe Market Attractiveness by Route of Administration, 2022 to 2033 Figure 98: Europe Market Attractiveness by Pet , 2022 to 2033 Figure 99: Europe Market Attractiveness by Application, 2022 to 2033 Figure 100: Europe Market Attractiveness by Country, 2022 to 2033 Figure 101: South Asia Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 102: South Asia Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 103: South Asia Market Value (US$ Million) by Pet , 2022 to 2033 Figure 104: South Asia Market Value (US$ Million) by Application, 2022 to 2033 Figure 105: South Asia Market Value (US$ Million) by Country, 2022 to 2033 Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 109: South Asia Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 110: South Asia Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 112: South Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 113: South Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 115: South Asia Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 116: South Asia Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 118: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 119: South Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 120: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 121: South Asia Market Attractiveness by Therapy, 2022 to 2033 Figure 122: South Asia Market Attractiveness by Route of Administration, 2022 to 2033 Figure 123: South Asia Market Attractiveness by Pet , 2022 to 2033 Figure 124: South Asia Market Attractiveness by Application, 2022 to 2033 Figure 125: South Asia Market Attractiveness by Country, 2022 to 2033 Figure 126: East Asia Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 127: East Asia Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 128: East Asia Market Value (US$ Million) by Pet , 2022 to 2033 Figure 129: East Asia Market Value (US$ Million) by Application, 2022 to 2033 Figure 130: East Asia Market Value (US$ Million) by Country, 2022 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 137: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 138: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 140: East Asia Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 141: East Asia Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 143: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 144: East Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 145: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 146: East Asia Market Attractiveness by Therapy, 2022 to 2033 Figure 147: East Asia Market Attractiveness by Route of Administration, 2022 to 2033 Figure 148: East Asia Market Attractiveness by Pet , 2022 to 2033 Figure 149: East Asia Market Attractiveness by Application, 2022 to 2033 Figure 150: East Asia Market Attractiveness by Country, 2022 to 2033 Figure 151: Oceania Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 152: Oceania Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 153: Oceania Market Value (US$ Million) by Pet , 2022 to 2033 Figure 154: Oceania Market Value (US$ Million) by Application, 2022 to 2033 Figure 155: Oceania Market Value (US$ Million) by Country, 2022 to 2033 Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 159: Oceania Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 160: Oceania Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 162: Oceania Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 163: Oceania Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 165: Oceania Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 166: Oceania Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 168: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 169: Oceania Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 170: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 171: Oceania Market Attractiveness by Therapy, 2022 to 2033 Figure 172: Oceania Market Attractiveness by Route of Administration, 2022 to 2033 Figure 173: Oceania Market Attractiveness by Pet , 2022 to 2033 Figure 174: Oceania Market Attractiveness by Application, 2022 to 2033 Figure 175: Oceania Market Attractiveness by Country, 2022 to 2033 Figure 176: MEA Market Value (US$ Million) by Therapy, 2022 to 2033 Figure 177: MEA Market Value (US$ Million) by Route of Administration, 2022 to 2033 Figure 178: MEA Market Value (US$ Million) by Pet , 2022 to 2033 Figure 179: MEA Market Value (US$ Million) by Application, 2022 to 2033 Figure 180: MEA Market Value (US$ Million) by Country, 2022 to 2033 Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2033 Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2033 Figure 184: MEA Market Value (US$ Million) Analysis by Therapy, 2018 to 2033 Figure 185: MEA Market Value Share (%) and BPS Analysis by Therapy, 2022 to 2033 Figure 186: MEA Market Y-o-Y Growth (%) Projections by Therapy, 2022 to 2033 Figure 187: MEA Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 188: MEA Market Value Share (%) and BPS Analysis by Route of Administration, 2022 to 2033 Figure 189: MEA Market Y-o-Y Growth (%) Projections by Route of Administration, 2022 to 2033 Figure 190: MEA Market Value (US$ Million) Analysis by Pet , 2018 to 2033 Figure 191: MEA Market Value Share (%) and BPS Analysis by Pet , 2022 to 2033 Figure 192: MEA Market Y-o-Y Growth (%) Projections by Pet , 2022 to 2033 Figure 193: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033 Figure 194: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2033 Figure 195: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2033 Figure 196: MEA Market Attractiveness by Therapy, 2022 to 2033 Figure 197: MEA Market Attractiveness by Route of Administration, 2022 to 2033 Figure 198: MEA Market Attractiveness by Pet , 2022 to 2033 Figure 199: MEA Market Attractiveness by Application, 2022 to 2033 Figure 200: MEA Market Attractiveness by Country, 2022 to 2033
Recommendations
Explore Healthcare Insights
View Reports